Library Catalogue
Incentives for global public health
Pogge Thomas
Incentives for global public health - Cambridge Cambridge University Press 2010 - 512p xix
Contents:
Introduction: access to essential medicines: public health and international law Thomas Pogge, Matthew Rimmer and Kim Rubenstein;
Part I. International Trade:
1. TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis Rochelle Cooper Dreyfuss;
2. The TRIPS waiver as a recognition of public health concerns in the WTO Andrew Mitchell and Tania Voon;
3. Public law challenges to the regulation of pharmaceutical patents in the US Bilateral Free Trade Agreements Hitoshi Nasu;
4. Global health and development: patents and public interest Elizabeth Siew Kuan Ng;
Part II. Innovation:
5. The Health Impact Fund: boosting innovation without obstructing free access Thomas Pogge;
6. The Health Impact Fund: a critique Kathleen Liddell;
7. A prize system as a partial solution to the health crisis in the developing world William W. Fisher and Talha Syed;
8. Innovation and insufficient evidence: the case for a WTO-WHO agreement on health technology safety and cost-effectiveness evaluation Thomas Faunce;
Part III. Intellectual Property:
9. Opening the dam: patent pools, innovation, and access to essential medicines Dianne Nicol and Jane Nielsen;
10. Open source drug discovery: a revolutionary paradigm or a utopian model? Krishna Ravi Srinivas;
11. Accessing and benefit sharing avian influenza viruses through the World Health Organisation: a CBD and TRIPS compromise thanks to Indonesia's sovereignty claim? Charles Lawson and Barbara Hocking;
12. The Lazarus effect: the (RED) campaign and creative capitalism Matthew Rimmer;
Part IV. Health-Care:
13. Beyond TRIPS: the role of non-state actors and access to essential medicines Noah Benjamin Novogrodsky;
14. Securing health through rights Katharine Young;
15. The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India Rajshree Chandra;
16. Tipping point: Thai compulsory licenses redefine essential medicines debate Jonathan Burton-MacLeod
9780521116565
1. Drug - Organization & Administration - Legislation2. Drugs - Essential - Supply & Distribution3. Health Service Accessibility
362.170000 / POG
Incentives for global public health - Cambridge Cambridge University Press 2010 - 512p xix
Contents:
Introduction: access to essential medicines: public health and international law Thomas Pogge, Matthew Rimmer and Kim Rubenstein;
Part I. International Trade:
1. TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis Rochelle Cooper Dreyfuss;
2. The TRIPS waiver as a recognition of public health concerns in the WTO Andrew Mitchell and Tania Voon;
3. Public law challenges to the regulation of pharmaceutical patents in the US Bilateral Free Trade Agreements Hitoshi Nasu;
4. Global health and development: patents and public interest Elizabeth Siew Kuan Ng;
Part II. Innovation:
5. The Health Impact Fund: boosting innovation without obstructing free access Thomas Pogge;
6. The Health Impact Fund: a critique Kathleen Liddell;
7. A prize system as a partial solution to the health crisis in the developing world William W. Fisher and Talha Syed;
8. Innovation and insufficient evidence: the case for a WTO-WHO agreement on health technology safety and cost-effectiveness evaluation Thomas Faunce;
Part III. Intellectual Property:
9. Opening the dam: patent pools, innovation, and access to essential medicines Dianne Nicol and Jane Nielsen;
10. Open source drug discovery: a revolutionary paradigm or a utopian model? Krishna Ravi Srinivas;
11. Accessing and benefit sharing avian influenza viruses through the World Health Organisation: a CBD and TRIPS compromise thanks to Indonesia's sovereignty claim? Charles Lawson and Barbara Hocking;
12. The Lazarus effect: the (RED) campaign and creative capitalism Matthew Rimmer;
Part IV. Health-Care:
13. Beyond TRIPS: the role of non-state actors and access to essential medicines Noah Benjamin Novogrodsky;
14. Securing health through rights Katharine Young;
15. The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India Rajshree Chandra;
16. Tipping point: Thai compulsory licenses redefine essential medicines debate Jonathan Burton-MacLeod
9780521116565
1. Drug - Organization & Administration - Legislation2. Drugs - Essential - Supply & Distribution3. Health Service Accessibility
362.170000 / POG